Press release
Melanoma Therapeutics Market: Global Industry Analysis and Forecast 2021-2026
This report provides critical insights on the market dynamics and enables strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Market structure: Overview, industry life cycle analysis, supply chain analysis.
Market environment analysis: Growth drivers and constraints
Market segment trend and forecast
Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
Attractive market segments and associated growth opportunities
Key success factors
This report studies the Melanoma Therapeutics Market and has segmented the market in few ways, keeping in mind the interest of all the stakeholders across the value chain. Following are the ways in which the market is segmented.
Therapy Trends
Based on therapy, the global melanoma therapeutics market has been categorized into chemotherapy, immunotherapy, targeted therapy, and radiation therapy.
• Among these, the chemotherapy segment held a substantial market share in 2020.
• This can be ascribed to its high adoption rate in the past few years owing to the growing incidence of cancer, especially skin cancers.
• Chemotherapy includes a wide range of therapeutics that involve protein-related synthetically derived products.
Regional Trends
By region, the North America market witnessed the highest market share in 2020 and is projected to register a robust CAGR during the review period.
• This is majorly attributed to increasing incidence of melanoma and other skin cancers in the region.
• In 2013, as per CDC, over 71,943 people were affected by melanoma.
• According to the American Cancer Society, this number is projected to go up to 87,100 cases in 2017.
• These statistics highlight the need for drugs that help in the management of melanoma over the following years.
Following are the key players in the Melanoma Therapeutics Market:
• AstraZeneca (UK),
• Amgen, Inc. (The U.S),
• F. Hoffman-La Roche Ltd. (Switzerland),
• Bristol-Myers Squibb Company (The U.S),
• Novartis AG (Switzerland),
• Merck & Co., Inc. (The U.S),
• Daiichi Sankyo Company Limited (Japan), and
• AB Sciences (France).
Click Here and Run Through the TOC of the Report:
https://www.stratviewresearch.com/toc/1643/melanoma-therapeutics-market.html
Highlights from the Report
Skin cancer generally is of three types¬– squamous cell carcinoma, basal cell carcinoma, and melanoma. Melanoma is a type of skin cancer that forms from pigment-containing cells in the skin. It is more common in locations with a sunny climate and is the most serious of all types of skin cancers. UV radiations are the prime cause of melanoma.
The Melanoma Therapeutics Market is expected to grow from USD 4.8 billion in 2020 to USD 9.1 billion by 2026 at a CAGR of over 11.3% during the forecast period.
Reasons to invest in this report -
The report comprises analytical representation of the Melanoma Therapeutics Market size along with current trends, challenges, and future estimations to depict imminent investment pockets. To understand the profitable trends and gain a stronger foothold, the report also helps the users with key information related to growth drivers, restraints, and opportunities in the market. The current Melanoma Therapeutics Market forecast is quantitatively analyzed from a particular time period of 5 years to benchmark the financial competency. The user will also get a detailed info about the market trends and share of key vendors.
Read More : https://www.stratviewresearch.com/1643/melanoma-therapeutics-market.html
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong experienced team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. The services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with the team –
Call @: +1-313-307-4176
Mail @: sales@stratviewresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Melanoma Therapeutics Market: Global Industry Analysis and Forecast 2021-2026 here
News-ID: 2475687 • Views: …
More Releases from Stratview Research
Aerospace Flight Control Systems Market to Reach US$ 11.2 Billion by 2034, Says …
The aerospace flight control systems market - encompassing the complex integrated components and technologies that enable pilots and onboard systems to manage aircraft direction, stability, and movement - is forecast to grow to US$ 11.2 billion by 2034, expanding at a CAGR of 3.3 % between 2025 and 2034. This growth is primarily driven by increasing aircraft production rates and the adoption of advanced flight technologies such as fly by…
Self-Contained Breathing Apparatus (SCBA) Market to Reach US$ 1.5 Billion by 202 …
The Self-Contained Breathing Apparatus (SCBA) Market is projected to reach US$ 1.5 billion by 2027, growing at a CAGR of 4.2% over 2022-2027. SCBA systems supply breathable air in hazardous or oxygen-deficient environments, primarily for firefighting and industrial safety applications. Rising demand from firefighting and mining industries is the single most important growth driver, structurally increasing demand as organizations adopt advanced respiratory protection to meet stringent safety regulations and reduce…
Automotive Carbon Ceramic Brake Market to Reach EU 425.9 Million by 2030, Says S …
The global automotive carbon ceramic brake market - which encompasses high performance braking systems using carbon and ceramic composite discs designed to deliver superior heat resistance, durability, and braking efficiency in luxury and performance vehicles - is projected to grow to EU 425.9 million by 2030, expanding at a CAGR of approximately 7.3% over 2025-2030. This growth is principally driven by increasing adoption of lightweight, high performance braking solutions in…
Wire Rope Market to Reach US$ 7.4 Billion by 2027, Says Stratview Research
The Wire Rope Market is projected to reach US$ 7.4 billion by 2027, expanding at a CAGR of 4.3% over the forecast period 2022-2027. Growth is primarily driven by ongoing investment in infrastructure development globally, which structurally increases demand for high-strength lifting, hoisting, and rigging solutions in construction, industrial, and maritime sectors. "Wire rope market expansion is anchored in the recovery of industrial activity and infrastructure spending after the pandemic,"…
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
